Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APDN

Applied DNA Sciences (APDN) Stock Price, News & Analysis

Applied DNA Sciences logo

About Applied DNA Sciences Stock (NASDAQ:APDN)

Key Stats

Today's Range
$4.61
$5.87
50-Day Range
$2.32
$6.15
52-Week Range
$0.29
$7.15
Volume
2.76 million shs
Average Volume
516,804 shs
Market Capitalization
$7.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Applied DNA Sciences, Inc. is a biotechnology company that specializes in the development and commercialization of DNA-based molecular technologies for product authentication, supply chain security, and anti-counterfeiting. Its proprietary SigNature® DNA taggants enable manufacturers and brand owners to embed unique, synthetic DNA markers into raw materials or finished goods, providing an immutable method of verifying origin and authenticity. This molecular tagging approach is designed to deter counterfeiting, diversion and the illicit resale of high-value products across a variety of end markets.

The company’s product portfolio includes SigNature® DNA solutions for pharmaceuticals, cosmetics, electronics and luxury goods, as well as SnapChain™ technology for cotton traceability. SnapChain™ offers a scalable way to certify fiber authenticity in textiles, helping retailers and consumers track the provenance of garments and raw materials. In addition to its tagging platforms, Applied DNA Sciences supplies molecular biology reagents—such as Helix Taq™ DNA polymerase—and offers contract laboratory services for forensic and diagnostic applications.

Headquartered in Stony Brook, New York, Applied DNA Sciences serves a global customer base spanning North America, Europe and Asia-Pacific. Its technologies address growing regulatory and consumer demands for transparency and integrity in supply chains, particularly in industries at high risk for counterfeit or diverted goods. Strategic partnerships with manufacturers, logistics providers and government agencies underpin the company’s efforts to expand adoption of its authentication platforms.

Under the leadership of President and Chief Executive Officer James A. Hayward, Applied DNA Sciences continues to innovate in molecular tagging and diagnostics. The company pursues both direct sales of its DNA solutions and licensing agreements with established supply-chain participants, aiming to extend its reach into new sectors such as agriculture, food safety and critical infrastructure protection.

AI Generated. May Contain Errors.

Receive APDN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APDN Stock News Headlines

The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
Applied DNA Sciences Announces New CEO Appointment
Earnings Scheduled For August 26, 2025
Applied DNA Sciences Focuses on LineaRx for Growth
See More Headlines

APDN Stock Analysis - Frequently Asked Questions

Applied DNA Sciences Inc (NASDAQ:APDN) issued its quarterly earnings results on Thursday, August, 14th. The technology company reported ($34.00) EPS for the quarter, topping analysts' consensus estimates of ($37.50) by $3.50. The technology company earned $0.30 million during the quarter, compared to analysts' expectations of $1.28 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 136.17% and a negative net margin of 399.91%.

Shares of Applied DNA Sciences reverse split on the morning of Sunday, June 1st 2025.The 1-15 reverse split was announced on Sunday, June 1st 2025. The number of shares owned by shareholders was adjusted after the market closes on Sunday, June 1st 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Applied DNA Sciences investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), Virgin Galactic (SPCE), AST SpaceMobile (ASTS) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
8/14/2025
Today
9/05/2026
Fiscal Year End
9/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:APDN
CIK
744452
Employees
70
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($923.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.99 million
Net Margins
-399.91%
Pretax Margin
-394.30%
Return on Equity
-136.17%
Return on Assets
-101.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.76
Quick Ratio
2.60

Sales & Book Value

Annual Sales
$3.74 million
Price / Sales
2.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$215.25 per share
Price / Book
0.03

Miscellaneous

Outstanding Shares
1,291,000
Free Float
1,289,000
Market Cap
$7.94 million
Optionable
Optionable
Beta
0.15

Social Links

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:APDN) was last updated on 9/5/2026 by MarketBeat.com Staff.
From Our Partners